Viewing Study NCT03288012


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-02-23 @ 11:35 AM
Study NCT ID: NCT03288012
Status: UNKNOWN
Last Update Posted: 2019-07-19
First Post: 2017-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
Sponsor: Sanquin Research & Blood Bank Divisions
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module